AGÕæÈ˹ٷ½

STOCK TITAN

[6-K] TAT Technologies Ltd Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

TAT Technologies Ltd. ("TATT") filed a Form 6-K detailing the completion of the underwritersâ€� over-allotment option connected to its May 29, 2025 public offering.

The option allowed Stifel and Truist, acting for the underwriting syndicate, to purchase an additional 622,500 ordinary shares (the “Option Shares�) at the public price of $26.00 per share, less underwriting discounts. Of these, the Company issued 242,298 new shares, while selling shareholders FIMI Opportunity V, L.P. and FIMI Israel Opportunity Five, L.P. sold 380,202 existing shares.

Financial impact: TATT generated gross proceeds of approximately $6.3 million from its portion of the Option Shares; it will not receive any proceeds from the selling shareholders� portion. Management states that net proceeds will be used for “general corporate purposes, including working capital and capital expenditures.�

The Over-Allotment exercise brings total shares sold in the offering to 4,772,500 (1,867,298 newly issued by the Company and 2,905,202 sold by existing holders when including the previously closed base deal). All shares were offered pursuant to the effective Form F-3 (File No. 333-286699). The filing also references customary indemnification and termination clauses contained in the May 29 underwriting agreement, and attaches the legal opinion (Exhibit 5.1) and a press release dated June 26, 2025 (Exhibit 99.1).

Key takeaways for investors:

  • Full option exercise suggests strong demand for TATT’s equity.
  • TATT secures incremental liquidity of $6.3 million without additional debt.
  • Issuance results in modest dilution to existing shareholders; exact percentage not disclosed in the filing.

TAT Technologies Ltd. ("TATT") ha presentato un modulo 6-K che dettaglia il completamento dell'opzione di sovrallocazione degli underwriter relativa all'offerta pubblica del 29 maggio 2025.

L'opzione ha permesso a Stifel e Truist, agendo per il sindacato di sottoscrittori, di acquistare ulteriori 622.500 azioni ordinarie (le “Azioni Opzione�) al prezzo pubblico di 26,00 dollari per azione, al netto degli sconti di sottoscrizione. Di queste, la Società ha emesso 242.298 nuove azioni, mentre gli azionisti venditori FIMI Opportunity V, L.P. e FIMI Israel Opportunity Five, L.P. hanno venduto 380.202 azioni esistenti.

Impatto finanziario: TATT ha generato proventi lordi di circa 6,3 milioni di dollari dalla sua quota delle Azioni Opzione; non riceverà proventi dalla quota delle azioni vendute dagli azionisti. La direzione afferma che i proventi netti saranno utilizzati per “scopi aziendali generali, inclusi capitale circolante e spese in conto capitale.�

L'esercizio dell'opzione di sovrallocazione porta il totale delle azioni vendute nell'offerta a 4.772.500 (1.867.298 di nuova emissione da parte della Società e 2.905.202 vendute da azionisti esistenti, includendo l'accordo base precedentemente chiuso). Tutte le azioni sono state offerte ai sensi del modulo F-3 efficace (File No. 333-286699). La documentazione fa inoltre riferimento alle consuete clausole di indennizzo e risoluzione contenute nell'accordo di sottoscrizione del 29 maggio, allegando l'opinione legale (Esibizione 5.1) e un comunicato stampa datato 26 giugno 2025 (Esibizione 99.1).

Punti chiave per gli investitori:

  • L'esercizio completo dell'opzione indica una forte domanda per il capitale di TATT.
  • TATT ottiene liquidità incrementale di 6,3 milioni di dollari senza indebitamento aggiuntivo.
  • L'emissione comporta una modesta diluizione per gli azionisti esistenti; la percentuale esatta non è stata divulgata nel documento.

TAT Technologies Ltd. ("TATT") presentó un Formulario 6-K detallando la finalización de la opción de sobresuscripción de los aseguradores relacionada con su oferta pública del 29 de mayo de 2025.

La opción permitió a Stifel y Truist, actuando para el sindicato de aseguradores, comprar un adicional de 622,500 acciones ordinarias (las “Acciones de Opción�) al precio público de $26.00 por acción, menos descuentos de aseguramiento. De estas, la Compañía emitió 242,298 acciones nuevas, mientras que los accionistas vendedores FIMI Opportunity V, L.P. y FIMI Israel Opportunity Five, L.P. vendieron 380,202 acciones existentes.

Impacto financiero: TATT generó ingresos brutos aproximados de $6.3 millones por su parte de las Acciones de Opción; no recibirá ingresos por la parte vendida por los accionistas vendedores. La gerencia indica que los ingresos netos se usarán para “propósitos corporativos generales, incluyendo capital de trabajo y gastos de capital.�

El ejercicio de la sobresuscripción eleva el total de acciones vendidas en la oferta a 4,772,500 (1,867,298 emitidas nuevas por la Compañía y 2,905,202 vendidas por accionistas existentes, incluyendo el acuerdo base cerrado previamente). Todas las acciones se ofrecieron conforme al Formulario F-3 vigente (Archivo No. 333-286699). La presentación también menciona cláusulas habituales de indemnización y terminación contenidas en el acuerdo de aseguramiento del 29 de mayo, y adjunta la opinión legal (Exhibición 5.1) y un comunicado de prensa fechado el 26 de junio de 2025 (Exhibición 99.1).

Puntos clave para los inversores:

  • El ejercicio completo de la opción sugiere una fuerte demanda por el capital de TATT.
  • TATT asegura liquidez incremental de $6.3 millones sin deuda adicional.
  • La emisión resulta en una dilución moderada para los accionistas existentes; el porcentaje exacto no se divulga en el documento.

TAT Technologies Ltd.("TATT")ëŠ� 2025ë…� 5ì›� 29ì� 공모와 ê´€ë ¨ëœ ì¸ìˆ˜ë‹¨ì˜ 초과배정 옵션 완료ë¥� ìƒì„¸íž� 기술í•� Form 6-Kë¥� 제출했습니다.

ì� 옵션ì� 통해 Stifelê³� TruistëŠ� ì¸ìˆ˜ë‹¨ì„ 대표하ì—� 공모가ì� 주당 26.00달러ì—서 ì¸ìˆ˜ 수수료를 ì°¨ê°í•� 가격으ë¡� 추가 622,500ì£� 보통ì£�(“옵ì…� 주ì‹â€�)ë¥� 매입í•� ìˆ� 있었습니ë‹�. ì� ì¤� 회사ëŠ� 242,298ì£�ì� 신주ë¥� 발행했으ë©�, 기존 주주ì� FIMI Opportunity V, L.P.와 FIMI Israel Opportunity Five, L.P.ëŠ� 380,202ì£�ì� 기존 주ì‹ì� 매ê°í–ˆìŠµë‹ˆë‹¤.

재무 ì˜í–¥: TATTëŠ� 옵션 ì£¼ì‹ ì¤� ìžì‚¬ 몫ì—ì„� ì•� 630ë§� 달러ì� ì´� 수ìµì� 창출했으ë©�, ë§¤ë„ ì£¼ì£¼ì� ëª«ì— ëŒ€í•´ì„œëŠ� 수ìµì� 받지 않습니다. ê²½ì˜ì§„ì€ ìˆœìˆ˜ìµì„ “운ì˜� ìžë³¸ ë°� ìžë³¸ ì§€ì¶œì„ í¬í•¨í•� ì¼ë°˜ 기업 목ì â€ì— 사용í•� 것ì´ë¼ê³  ë°í˜”습니ë‹�.

초과배정 옵션 행사ë¡� ì´ë²ˆ 공모ì—서 ì´� ë§¤ë„ ì£¼ì‹ ìˆ˜ëŠ” 4,772,500ì£�(회사ì—서 새로 발행í•� 1,867,298주와 기존 보유ìžê°€ 매ë„í•� 2,905,202ì£�, ì´ì „ì—� 마ê°ë� 기본 거래 í¬í•¨)ë¡� ì¦ê°€í–ˆìŠµë‹ˆë‹¤. 모든 주ì‹ì€ 유효í•� Form F-3(íŒŒì¼ ë²ˆí˜¸ 333-286699)ì—� ë”°ë¼ ì œê³µë˜ì—ˆìŠµë‹ˆë‹�. 제출 문서ì—는 5ì›� 29ì� ì¸ìˆ˜ 계약ì—� í¬í•¨ë� ì¼ë°˜ì ì¸ ë©´ì±… ë°� 종료 ì¡°í•­ë� 언급ë˜ì–´ 있으ë©�, 법률 ì˜ê²¬ì„�(전시ë¬� 5.1)와 2025ë…� 6ì›� 26ì¼ìž ë³´ë„ìžë£Œ(전시ë¬� 99.1)ë� 첨부ë˜ì–´ 있습니다.

투ìžìžë¥¼ 위한 주요 ë‚´ìš©:

  • 옵션 ì „ì•¡ 행사ëŠ� TATT 주ì‹ì—� 대í•� 강한 수요ë¥� 시사합니ë‹�.
  • TATTëŠ� 추가 ë¶€ì±� ì—†ì´ 630ë§� 달러ì� 유ë™ì„±ì„ 확보했습니다.
  • 신주 ë°œí–‰ì€ ê¸°ì¡´ 주주들ì—ê²� 소í­ì� í¬ì„ 효과ë¥� 가져오ë©�, 정확í•� ë¹„ìœ¨ì€ ì œì¶œ 문서ì—� 공개ë˜ì§€ 않았습니ë‹�.

TAT Technologies Ltd. (« TATT ») a déposé un formulaire 6-K détaillant l’achèvement de l’option de surallocation des souscripteurs liée à son offre publique du 29 mai 2025.

L’option a permis à Stifel et Truist, agissant pour le syndicat de souscription, d’acheter 622 500 actions ordinaires supplémentaires (les « Actions d’Option ») au prix public de 26,00 $ par action, moins les remises de souscription. Parmi celles-ci, la Société a émis 242 298 nouvelles actions, tandis que les actionnaires vendeurs FIMI Opportunity V, L.P. et FIMI Israel Opportunity Five, L.P. ont vendu 380 202 actions existantes.

Impact financier : TATT a généré des produits bruts d’environ 6,3 millions de dollars sur sa part des Actions d’Option ; elle ne recevra aucun produit provenant de la part des actionnaires vendeurs. La direction indique que les produits nets seront utilisés à des fins « générales d’entreprise, y compris le fonds de roulement et les dépenses en capital ».

L’exercice de la surallocation porte le total des actions vendues dans l’offre à 4 772 500 (1 867 298 nouvellement émises par la Société et 2 905 202 vendues par des détenteurs existants, y compris l’accord de base précédemment clos). Toutes les actions ont été offertes conformément au formulaire F-3 en vigueur (dossier n° 333-286699). Le dépôt fait également référence aux clauses habituelles d’indemnisation et de résiliation contenues dans l’accord de souscription du 29 mai, et joint l’avis juridique (Exhibit 5.1) ainsi qu’un communiqué de presse daté du 26 juin 2025 (Exhibit 99.1).

Points clés pour les investisseurs :

  • L’exercice complet de l’option suggère une forte demande pour les actions de TATT.
  • TATT sécurise une liquidité supplémentaire de 6,3 millions de dollars sans dette supplémentaire.
  • L’émission entraîne une dilution modérée pour les actionnaires existants ; le pourcentage exact n’est pas divulgué dans le dépôt.

TAT Technologies Ltd. ("TATT") hat ein Formular 6-K eingereicht, das den Abschluss der Mehrzuteilungsoption der Underwriter im Zusammenhang mit dem öffentlichen Angebot vom 29. Mai 2025 beschreibt.

Die Option ermöglichte es Stifel und Truist, im Auftrag des Underwriting-Syndikats zusätzliche 622.500 Stammaktien (die „Optionsaktien�) zum öffentlichen Preis von 26,00 USD pro Aktie abzüglich Underwriting-Rabatten zu kaufen. Davon hat das Unternehmen 242.298 neue Aktien ausgegeben, während die verkaufenden Aktionäre FIMI Opportunity V, L.P. und FIMI Israel Opportunity Five, L.P. 380.202 bestehende Aktien verkauft haben.

Finanzielle Auswirkungen: TATT erzielte aus seinem Anteil an den Optionsaktien Bruttoerlöse von etwa 6,3 Millionen USD; von der verkauften Aktienmenge der Aktionäre erhält es keine Erlöse. Das Management gibt an, dass die Nettoerlöse für „allgemeine Unternehmenszwecke, einschließlich Betriebskapital und Investitionsausgaben� verwendet werden sollen.

Die Ausübung der Mehrzuteilungsoption erhöht die insgesamt im Angebot verkauften Aktien auf 4.772.500 (1.867.298 neu vom Unternehmen ausgegebene und 2.905.202 von bestehenden Inhabern verkaufte Aktien, einschließlich des zuvor abgeschlossenen Basisgeschäfts). Alle Aktien wurden gemäß dem wirksamen Formular F-3 (Aktenzeichen 333-286699) angeboten. Die Einreichung verweist zudem auf übliche Entschädigungs- und Kündigungsklauseln im Underwriting-Vertrag vom 29. Mai und enthält die Rechtsmeinung (Anlage 5.1) sowie eine Pressemitteilung vom 26. Juni 2025 (Anlage 99.1).

Wichtige Erkenntnisse für Investoren:

  • Die vollständige Ausübung der Option deutet auf eine starke Nachfrage nach TATT-Aktien hin.
  • TATT sichert sich eine zusätzliche Liquidität von 6,3 Millionen USD ohne zusätzliche Verschuldung.
  • Die Ausgabe führt zu einer moderaten Verwässerung der bestehenden Aktionäre; der genaue Prozentsatz wird in der Einreichung nicht offengelegt.
Positive
  • Full exercise of the underwritersâ€� option reflects strong market demand for TATT shares.
  • $6.3 million in additional gross proceeds strengthens liquidity without adding debt.
  • Increased public float may improve share trading liquidity.
Negative
  • Issuance of 242,298 new shares introduces dilution to existing shareholders.
  • Company receives no proceeds from the 380,202 shares sold by the selling shareholders.

Insights

TL;DR: Successful over-allotment adds $6.3 M cash, signals demand, but modest dilution persists—overall positive.

The full take-up of the underwriters� option indicates a healthy order book and market confidence in TAT Technologies� story post-offering. Incremental proceeds bolster liquidity for working capital and capex without incurring leverage, improving balance-sheet flexibility. Because only 242,298 of the 622,500 Option Shares are newly issued, cash inflow is limited but still meaningful for a company of TATT’s scale. The remainder, sold by FIMI funds, increases free float and may enhance trading liquidity, though it does not benefit the company financially. Dilution impact is unavoidable, yet the filing does not quantify it; investors should monitor EPS effect in future reports. Overall, the transaction is modestly accretive to financial optionality and market perception.

TAT Technologies Ltd. ("TATT") ha presentato un modulo 6-K che dettaglia il completamento dell'opzione di sovrallocazione degli underwriter relativa all'offerta pubblica del 29 maggio 2025.

L'opzione ha permesso a Stifel e Truist, agendo per il sindacato di sottoscrittori, di acquistare ulteriori 622.500 azioni ordinarie (le “Azioni Opzione�) al prezzo pubblico di 26,00 dollari per azione, al netto degli sconti di sottoscrizione. Di queste, la Società ha emesso 242.298 nuove azioni, mentre gli azionisti venditori FIMI Opportunity V, L.P. e FIMI Israel Opportunity Five, L.P. hanno venduto 380.202 azioni esistenti.

Impatto finanziario: TATT ha generato proventi lordi di circa 6,3 milioni di dollari dalla sua quota delle Azioni Opzione; non riceverà proventi dalla quota delle azioni vendute dagli azionisti. La direzione afferma che i proventi netti saranno utilizzati per “scopi aziendali generali, inclusi capitale circolante e spese in conto capitale.�

L'esercizio dell'opzione di sovrallocazione porta il totale delle azioni vendute nell'offerta a 4.772.500 (1.867.298 di nuova emissione da parte della Società e 2.905.202 vendute da azionisti esistenti, includendo l'accordo base precedentemente chiuso). Tutte le azioni sono state offerte ai sensi del modulo F-3 efficace (File No. 333-286699). La documentazione fa inoltre riferimento alle consuete clausole di indennizzo e risoluzione contenute nell'accordo di sottoscrizione del 29 maggio, allegando l'opinione legale (Esibizione 5.1) e un comunicato stampa datato 26 giugno 2025 (Esibizione 99.1).

Punti chiave per gli investitori:

  • L'esercizio completo dell'opzione indica una forte domanda per il capitale di TATT.
  • TATT ottiene liquidità incrementale di 6,3 milioni di dollari senza indebitamento aggiuntivo.
  • L'emissione comporta una modesta diluizione per gli azionisti esistenti; la percentuale esatta non è stata divulgata nel documento.

TAT Technologies Ltd. ("TATT") presentó un Formulario 6-K detallando la finalización de la opción de sobresuscripción de los aseguradores relacionada con su oferta pública del 29 de mayo de 2025.

La opción permitió a Stifel y Truist, actuando para el sindicato de aseguradores, comprar un adicional de 622,500 acciones ordinarias (las “Acciones de Opción�) al precio público de $26.00 por acción, menos descuentos de aseguramiento. De estas, la Compañía emitió 242,298 acciones nuevas, mientras que los accionistas vendedores FIMI Opportunity V, L.P. y FIMI Israel Opportunity Five, L.P. vendieron 380,202 acciones existentes.

Impacto financiero: TATT generó ingresos brutos aproximados de $6.3 millones por su parte de las Acciones de Opción; no recibirá ingresos por la parte vendida por los accionistas vendedores. La gerencia indica que los ingresos netos se usarán para “propósitos corporativos generales, incluyendo capital de trabajo y gastos de capital.�

El ejercicio de la sobresuscripción eleva el total de acciones vendidas en la oferta a 4,772,500 (1,867,298 emitidas nuevas por la Compañía y 2,905,202 vendidas por accionistas existentes, incluyendo el acuerdo base cerrado previamente). Todas las acciones se ofrecieron conforme al Formulario F-3 vigente (Archivo No. 333-286699). La presentación también menciona cláusulas habituales de indemnización y terminación contenidas en el acuerdo de aseguramiento del 29 de mayo, y adjunta la opinión legal (Exhibición 5.1) y un comunicado de prensa fechado el 26 de junio de 2025 (Exhibición 99.1).

Puntos clave para los inversores:

  • El ejercicio completo de la opción sugiere una fuerte demanda por el capital de TATT.
  • TATT asegura liquidez incremental de $6.3 millones sin deuda adicional.
  • La emisión resulta en una dilución moderada para los accionistas existentes; el porcentaje exacto no se divulga en el documento.

TAT Technologies Ltd.("TATT")ëŠ� 2025ë…� 5ì›� 29ì� 공모와 ê´€ë ¨ëœ ì¸ìˆ˜ë‹¨ì˜ 초과배정 옵션 완료ë¥� ìƒì„¸íž� 기술í•� Form 6-Kë¥� 제출했습니다.

ì� 옵션ì� 통해 Stifelê³� TruistëŠ� ì¸ìˆ˜ë‹¨ì„ 대표하ì—� 공모가ì� 주당 26.00달러ì—서 ì¸ìˆ˜ 수수료를 ì°¨ê°í•� 가격으ë¡� 추가 622,500ì£� 보통ì£�(“옵ì…� 주ì‹â€�)ë¥� 매입í•� ìˆ� 있었습니ë‹�. ì� ì¤� 회사ëŠ� 242,298ì£�ì� 신주ë¥� 발행했으ë©�, 기존 주주ì� FIMI Opportunity V, L.P.와 FIMI Israel Opportunity Five, L.P.ëŠ� 380,202ì£�ì� 기존 주ì‹ì� 매ê°í–ˆìŠµë‹ˆë‹¤.

재무 ì˜í–¥: TATTëŠ� 옵션 ì£¼ì‹ ì¤� ìžì‚¬ 몫ì—ì„� ì•� 630ë§� 달러ì� ì´� 수ìµì� 창출했으ë©�, ë§¤ë„ ì£¼ì£¼ì� ëª«ì— ëŒ€í•´ì„œëŠ� 수ìµì� 받지 않습니다. ê²½ì˜ì§„ì€ ìˆœìˆ˜ìµì„ “운ì˜� ìžë³¸ ë°� ìžë³¸ ì§€ì¶œì„ í¬í•¨í•� ì¼ë°˜ 기업 목ì â€ì— 사용í•� 것ì´ë¼ê³  ë°í˜”습니ë‹�.

초과배정 옵션 행사ë¡� ì´ë²ˆ 공모ì—서 ì´� ë§¤ë„ ì£¼ì‹ ìˆ˜ëŠ” 4,772,500ì£�(회사ì—서 새로 발행í•� 1,867,298주와 기존 보유ìžê°€ 매ë„í•� 2,905,202ì£�, ì´ì „ì—� 마ê°ë� 기본 거래 í¬í•¨)ë¡� ì¦ê°€í–ˆìŠµë‹ˆë‹¤. 모든 주ì‹ì€ 유효í•� Form F-3(íŒŒì¼ ë²ˆí˜¸ 333-286699)ì—� ë”°ë¼ ì œê³µë˜ì—ˆìŠµë‹ˆë‹�. 제출 문서ì—는 5ì›� 29ì� ì¸ìˆ˜ 계약ì—� í¬í•¨ë� ì¼ë°˜ì ì¸ ë©´ì±… ë°� 종료 ì¡°í•­ë� 언급ë˜ì–´ 있으ë©�, 법률 ì˜ê²¬ì„�(전시ë¬� 5.1)와 2025ë…� 6ì›� 26ì¼ìž ë³´ë„ìžë£Œ(전시ë¬� 99.1)ë� 첨부ë˜ì–´ 있습니다.

투ìžìžë¥¼ 위한 주요 ë‚´ìš©:

  • 옵션 ì „ì•¡ 행사ëŠ� TATT 주ì‹ì—� 대í•� 강한 수요ë¥� 시사합니ë‹�.
  • TATTëŠ� 추가 ë¶€ì±� ì—†ì´ 630ë§� 달러ì� 유ë™ì„±ì„ 확보했습니다.
  • 신주 ë°œí–‰ì€ ê¸°ì¡´ 주주들ì—ê²� 소í­ì� í¬ì„ 효과ë¥� 가져오ë©�, 정확í•� ë¹„ìœ¨ì€ ì œì¶œ 문서ì—� 공개ë˜ì§€ 않았습니ë‹�.

TAT Technologies Ltd. (« TATT ») a déposé un formulaire 6-K détaillant l’achèvement de l’option de surallocation des souscripteurs liée à son offre publique du 29 mai 2025.

L’option a permis à Stifel et Truist, agissant pour le syndicat de souscription, d’acheter 622 500 actions ordinaires supplémentaires (les « Actions d’Option ») au prix public de 26,00 $ par action, moins les remises de souscription. Parmi celles-ci, la Société a émis 242 298 nouvelles actions, tandis que les actionnaires vendeurs FIMI Opportunity V, L.P. et FIMI Israel Opportunity Five, L.P. ont vendu 380 202 actions existantes.

Impact financier : TATT a généré des produits bruts d’environ 6,3 millions de dollars sur sa part des Actions d’Option ; elle ne recevra aucun produit provenant de la part des actionnaires vendeurs. La direction indique que les produits nets seront utilisés à des fins « générales d’entreprise, y compris le fonds de roulement et les dépenses en capital ».

L’exercice de la surallocation porte le total des actions vendues dans l’offre à 4 772 500 (1 867 298 nouvellement émises par la Société et 2 905 202 vendues par des détenteurs existants, y compris l’accord de base précédemment clos). Toutes les actions ont été offertes conformément au formulaire F-3 en vigueur (dossier n° 333-286699). Le dépôt fait également référence aux clauses habituelles d’indemnisation et de résiliation contenues dans l’accord de souscription du 29 mai, et joint l’avis juridique (Exhibit 5.1) ainsi qu’un communiqué de presse daté du 26 juin 2025 (Exhibit 99.1).

Points clés pour les investisseurs :

  • L’exercice complet de l’option suggère une forte demande pour les actions de TATT.
  • TATT sécurise une liquidité supplémentaire de 6,3 millions de dollars sans dette supplémentaire.
  • L’émission entraîne une dilution modérée pour les actionnaires existants ; le pourcentage exact n’est pas divulgué dans le dépôt.

TAT Technologies Ltd. ("TATT") hat ein Formular 6-K eingereicht, das den Abschluss der Mehrzuteilungsoption der Underwriter im Zusammenhang mit dem öffentlichen Angebot vom 29. Mai 2025 beschreibt.

Die Option ermöglichte es Stifel und Truist, im Auftrag des Underwriting-Syndikats zusätzliche 622.500 Stammaktien (die „Optionsaktien�) zum öffentlichen Preis von 26,00 USD pro Aktie abzüglich Underwriting-Rabatten zu kaufen. Davon hat das Unternehmen 242.298 neue Aktien ausgegeben, während die verkaufenden Aktionäre FIMI Opportunity V, L.P. und FIMI Israel Opportunity Five, L.P. 380.202 bestehende Aktien verkauft haben.

Finanzielle Auswirkungen: TATT erzielte aus seinem Anteil an den Optionsaktien Bruttoerlöse von etwa 6,3 Millionen USD; von der verkauften Aktienmenge der Aktionäre erhält es keine Erlöse. Das Management gibt an, dass die Nettoerlöse für „allgemeine Unternehmenszwecke, einschließlich Betriebskapital und Investitionsausgaben� verwendet werden sollen.

Die Ausübung der Mehrzuteilungsoption erhöht die insgesamt im Angebot verkauften Aktien auf 4.772.500 (1.867.298 neu vom Unternehmen ausgegebene und 2.905.202 von bestehenden Inhabern verkaufte Aktien, einschließlich des zuvor abgeschlossenen Basisgeschäfts). Alle Aktien wurden gemäß dem wirksamen Formular F-3 (Aktenzeichen 333-286699) angeboten. Die Einreichung verweist zudem auf übliche Entschädigungs- und Kündigungsklauseln im Underwriting-Vertrag vom 29. Mai und enthält die Rechtsmeinung (Anlage 5.1) sowie eine Pressemitteilung vom 26. Juni 2025 (Anlage 99.1).

Wichtige Erkenntnisse für Investoren:

  • Die vollständige Ausübung der Option deutet auf eine starke Nachfrage nach TATT-Aktien hin.
  • TATT sichert sich eine zusätzliche Liquidität von 6,3 Millionen USD ohne zusätzliche Verschuldung.
  • Die Ausgabe führt zu einer moderaten Verwässerung der bestehenden Aktionäre; der genaue Prozentsatz wird in der Einreichung nicht offengelegt.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
 
For the Month of June 2025

Commission File Number 000-16050

TAT Technologies Ltd.
(Translation of registrant’s name into English)

5 Hamelacha Street, Netanya 4250540, Israel
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒        Form 40-F

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐        No

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A


Explanatory Note

As set forth in the Report on Form 6-K of TAT Technologies Ltd. (the “Company”), dated June 3, 2025, the Company entered into an underwriting agreement (the “Underwriting Agreement”) on May 29, 2025 with FIMI Opportunity V, L.P. and FIMI Israel Opportunity Five, Limited Partnership, as selling shareholders (the “Selling Shareholders”), and Stifel, Nicolaus & Company, Incorporated and Truist Securities, Inc., as representatives of the several underwriters named in Schedule I thereto (the “Underwriters”), relating to an underwritten public offering of 4,150,000 ordinary shares, no par value per share, of the Company at a public offering price of $26.00 per share, of which the Company sold 1,625,000 ordinary shares and the Selling Shareholders sold 2,525,000 ordinary shares (collectively, the “Firm Shares”). As previously announced, the sale and issuance of the Firm Shares was completed on June 3, 2025.

Pursuant to the Underwriting Agreement, the Company and the Selling Shareholders also granted the Underwriters an option to purchase up to an additional 242,298 and 380,202 ordinary shares from the Company and the Selling Shareholders, respectively (collectively, the “Option Shares”), at the public offering price less the underwriting discount and commissions (the “Underwriters’ Option”).

On June 26, 2025, following the exercise by the Underwriters of the Underwriters’ Option in full, the sale and issuance of the Option Shares was completed.

The total gross proceeds of the sale and issuance of the Option Shares to the Company, before underwriting discounts and commissions and estimated offering expenses, were $6.3 million. The Company did not receive any proceeds from the sale of Option Shares by the Selling Shareholders. The Company intends to use the net proceeds that it will receive from the sale and issuance of the Option Shares for general corporate purposes, including working capital and capital expenditures. 

The Underwriting Agreement contains customary representations, warranties and agreements by the Company and the Selling Shareholders, customary conditions to closing, indemnification obligations of us, the Selling Shareholders and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by such parties. The foregoing description of the Underwriting Agreement is only a summary and is qualified in its entirety by reference to the Underwriting Agreement, a copy of which was attached as Exhibit 1.1 to the Company’s Report on Form 6-K, dated June 3, 2025.

The offering, including the sale and issuance of the Option Shares, was made pursuant to the Company’s effective registration statement on Form F-3 (File No. 333-286699), previously filed with the Securities and Exchange Commission. A copy of the opinion of Naschitz, Brandes, Amir & Co., Advocates relating to the legality of the sale and issuance of the Option Shares is attached as Exhibit 5.1 to this Report.

On June 26, 2025, the Company issued a press release titled “TAT Technologies Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Ordinary Shares in Connection with its Public Offering”.

This Report on Form 6-K and Exhibit 5.1 hereto are incorporated by reference into the Company’s registration statements on Form S-8 (File Nos. 333-219031, 333-228345, 333-268906 and 333-286702) and Form F-3 (File No. 333-286699), and shall be a part thereof from the date on which this Report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

The Company hereby furnishes the following documents as Exhibits 5.1 and 99.1:
 
Exhibit 5.1:          Opinion of Naschitz, Brandes, Amir & Co., Advocates as to the validity of the ordinary shares.

Exhibit 99.1:          Company Press Release, dated June 26, 2025, “TAT Technologies Announces Full Exercise and Closing of Underwriters’  Option to Purchase Additional Ordinary Shares in Connection with its Public Offering”.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TAT Technologies Ltd.

By:
/S/ Ehud Ben-Yair
Name:
Ehud Ben-Yair
Title:
Chief Financial Officer

Date: June 26, 2025




FAQ

How many additional TATT shares were sold through the over-allotment option?

622,500 ordinary shares were sold in total�242,298 issued by the Company and 380,202 by selling shareholders.

What proceeds did TAT Technologies (TATT) receive from the option exercise?

TATT received gross proceeds of approximately $6.3 million before underwriting fees and expenses.

Will the selling shareholders� portion provide cash to the Company?

No. The Company will not receive any proceeds from the 380,202 shares sold by the selling shareholders.

How does TATT plan to use the net proceeds from the offering?

Management intends to allocate funds for general corporate purposes, working capital, and capital expenditures.

Under which registration statement was the offering conducted?

The shares were offered under the effective Form F-3 registration statement (File No. 333-286699).
Tat Techn

NASDAQ:TATT

TATT Rankings

TATT Latest News

TATT Latest SEC Filings

TATT Stock Data

411.13M
12.43M
53.18%
0.13%
Aerospace & Defense
Industrials
Israel
Netanya